Daiichi Sankyo isn't taking chances on Ranbaxy Laboratories' ability to keep turning out FDA-compliant drugs. The Japanese drugmaker, which owns the controlling interest in the Indian company, has dispatched two executives to the Punjab facility to keep a close eye on operations there, The Economic Times says. Report